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Reverse chromosome painting is an approach for determining the nature of structural chromosome aberrations including those inaccessible to G banding. That is, in cases where results from G banding are unclear, chromosome paints can be made from abnormal chromosomes and used as in situ hybridisation probes onto normal metaphases.' The procedure involves chromosome sorting by flow cytometry and the identification and sorting of aberrant peaks on a flow karyotype with subsequent amplification and labelling by degenerate oligonucleotide primed (DOP)-PCR.' Although invaluable for locating deletions and rearrangements between different chromosomes, it is not adequate for determining the origin of intrachromosomal duplications. For example, a paint made from a deleted chromosome will hybridise to its complementary normal chromosome except in the deleted region, but a paint made from a chromosome with an intrachromosomal duplication will hybridise only to the complementary normal chromosome and nowhere else on the karyotype. To circumvent this problem, we developed a novel approach which involves simultaneous hybridisation of the duplicated chromosome and its normal homologue using dual colour fluorescent in situ hybridisation. The paint derived from the duplicated chromosome hybridises more strongly in the duplicated region than in its homologue. This takes advantage of a relative over-representation of probe DNA producing a stronger signal in the duplicated region. Using this approach, small intrachromosomal duplications were detected easily using image processing software designed for comparative genome hybridisation (CGH). This novel approach is similar to CGH' in that it measures the relative hybridisation of probe DNA along the chromosomal axis; however, in this case, the analysis is performed on one chromosome pair alone.
Methods
In a preliminary series, four patients were investigated for cytogenetic abnormalities at the Clinical Cytogenetic Laboratory, East Anglian Genetics Service, Addenbrooke's NHS Trust, Cambridge, UK. Classical G banding analysis showed that each had a chromosomal duplication, but the origin of the duplication could not be accurately determined. Patient 1 had a duplication of the short arm of chromosome 2 apparently originating from the centromeric region, patient 2 had a duplication in the long arm of chromosome 3 apparently originating from around band 3q25, patient 3 had a duplication of the terminal portion of the long arm of chromosome 5, and patient 4 had a duplication of the long arm of chromosome 12 originating from around band 12q24. Thus, in each case, the aberrant chromosome was identified by G banding before flow sorting.
Chromosome paints from each patient were generated as follows. Chromosomes were prepared for flow sorting as described previously,' spun briefly (100 g for one minute to remove any debris), then the supernatant stained with 2 gg/ml Hoechst 33258 (Sigma) and 40 Both for CGH and chromosome specific CGH experiments, Custom CGH software (Vysis "Quips" package) determined the chromosomal axis and measured the relative red/green fluorescence ratio along it. In the case of chromosome specific CGH, analysis was performed only on the chromosome pair on which hybridisation occurred by manually selecting only the two chromosomes ofinterest. The rest of the karyotype was thus disregarded. Following analysis of six to 10 metaphases, results were expressed as a ratio of red/green fluorescence and considered to represent a duplication when that ratio exceeded 1.15:1. In CGH experiments, ratios of between 1.15:1 and 1.25:1 are commonly used."4 We chose the lower threshold to achieve maximum sensitivity when comparing CGH with chromosome specific CGH. Since fluorescent in situ hybridisation is not 100% efficient, the theoretical ratio of 1.5:1 is never reached.
Results
In each case, comparison with G banding data suggested that the duplication was tandem. This was detected for patients 1 and 4 using CGH and for all patients using chromosome specific CGH; results are summarised in table 1. Fig 2 shows the CGH program profiles comparing the use of CGH with that of chromosome specific CGH. For patients 1 and 4, the duplications on chromosomes 2 and 12 could be detected easily by both approaches although the peak for the chromosome specific CGH was higher and more clearly defined; indeed for patient 4, it exceeds a ratio of 1.5:1, which is greater than can be theoretically achieved by CGH. Fig 3 shows that the smallest of duplications (for patient 2 on chromosome 3) can be detected visually as an over-representation of red in the duplicated region. We were unable to detect the duplication in patients 2 and 3 using CGH; however, in both cases, we were successful using chromosome specific CGH. In patient 3, the duplication was at or near the end of the long arm of chromosome 5. The problems associated with detecting terminal duplications and deletions by CGH are well documented'; that is, CGH experiments commonly show apparent duplications or deletions at some telomeres which have subsequently been found not to be present; this seems to be the case for patient 4 where both telomeres show an apparent duplication. Conversely, duplications present at the termini of chromosomes can be missed by CGH and this seems to be the case for patient 3. In our limited experience of chromosome specific CGH, a duplication at the terminus of chromosome 5 was easily detected and we have not yet seen an aberrant peak associated with the end of any chromosome.
Discussion
The use of the technique described here is limited to laboratories equipped for flow sorting; however, recovery of duplicated chromosomes could also be achieved by chromosome microdissection.4 Both approaches are laborious and require actively dividing samples to make metaphases and thus chromosome specific CGH is unlikely to be used as widely as conventional CGH. Nevertheless, our data show that chromosome specific CGH can detect duplications (and, presumably, amplifications or deletions) that may be missed by CGH. This is because the ratio of hybridisation of abnormal/normal DNA in the duplicated region is 2:1. It is 3:2 in a CGH experiment owing to the presence of the normal homologue in the test hybridisation. CGH has been cited as a means of detecting constitutional duplications in patients where G banding results are equivocal5; our results suggest that this new approach may be a more sensitive way of doing this, particularly where terminal duplications and deletions are concerned. It is unlikely that it would be used as a routine diagnostic tool, but it may prove invaluable in particular cases, for instance when the duplicated region contains a gene of interest. In the absence of molecular data, we cannot accurately determine the size of the duplications; further, we cannot rule out the possibility that other laboratories may be able to detect the smaller deletions by regular CGH. Indeed, several groups have reported the detection of aberrations as small as 10-20 Mb by CGH.6 8 However, our data represent a set of controlled experiments where all other factors were kept equal other than the choice of probe; they clearly suggest that chromosome specific CGH is the more sensitive approach.
A more wide ranging application for this technology than the detection of duplications in patient material, however, is likely to be in the analysis of tumour cell lines. In addition to the added sensitivity provided by this 
The major technical drawback of this technique compared to CGH is the inherent necessity of previous flow sorting or chromosome microdissection.' Thus it is limited to the analysis of actively growing cells from which chromosomes can be prepared; CGH on the other hand requires only a small amount of genomic DNA. Nevertheless, if these problems can be circumvented, a chromosome specific CGH experiment is much easier to perform than one involving regular CGH as analysis time is much shorter. This is because only one chromosome pair is analysed, the classification of chromosomes by DAPI banding is not necessary as the chromosome pair is clearly painted, and a number of experiments, each from a different patient sample, can be performed on one slide provided that there is a different chromosome of interest. Another potential drawback is the ability of flow sorting to differentiate the duplicated from the normal chromosome. The precise resolution power of flow sorting in this regard is unclear, but our results suggest that it is the hybridisation which is the rate limiting factor since, in patient 2, the chromosomes were easily separated on the flow karyotype whereas the hybridisation ratio only just exceeded 1. 15: 1.
Finally, in this report we show that ratio analyses can be made from picogram quantities (that is, approximately 400 chromosomes) of DNA amplified by DOP-PCR. This may find applicability not only for chromosome specific CGH but for regular CGH also, for instance, in analysis of tumour progression from archive material, or for detecting aneuploidy diagnostically from small numbers of cells, perhaps for preimplantation diagnosis or in rare fetal cells isolated from the maternal circulation. Thus, we provide some evidence that DOP-PCR, in addition to being a powerful tool for amplifying small quantities of DNA, appears to amplify all or most of the euchromatic regions of the genome equally.
In summary, chromosome specific CGH uses the power of DOP-PCR to amplify small amounts of DNA equally and provides a sensitive means for the detection of intrachromosomal duplications. Although it has a number of (mostly technical) drawbacks 
